GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Compound class:
Synthetic organic
Comment: This is one of the more potent compounds claimed in patent WO2023245150A1 (Prelude Therapeutics) as lysine acetyltransferase 6A (KAT6A) degraders [1]. It is a PROTAC heterobifunctional molecule with a thalidomide-based cereblon ubiquitin ligase binding moiety linked to a selective KAT6A binding ligand. It promotes formation of a ternary complex that directs KAT6A protein for proteosomal degradation. This mechanism is proposed as an alternative to direct enzyme inhibition.
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
| Ligand families/groups | PROTACs, molecular glues and other degraders |
Database Links ![]() |
|
| GtoPdb PubChem SID | 518520716 |
| PubChem CID | 170545846 |
| Search Google for chemical match using the InChIKey | XVJJGQFASNNHCT-UHFFFAOYSA-N |
| Search Google for chemicals with the same backbone | XVJJGQFASNNHCT |
| UniChem Compound Search for chemical match using the InChIKey | XVJJGQFASNNHCT-UHFFFAOYSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | XVJJGQFASNNHCT-UHFFFAOYSA-N |